During the past decade, Centre Hospitalier William Morey conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 1 clinical trials were completed, i.e. on average, 2.6% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 1 clinical trials were completed. i.e. 6.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier William Morey" #1 sponsor was "The Lymphoma Academic Research Organisation" with 10 trials, followed by "Intergroupe Francophone du Myelome" with 5 trials sponsored, "Federation Francophone de Cancerologie Digestive" with 4 trials sponsored, "ARCAGY/ GINECO GROUP" with 3 trials sponsored and "Centre Hospitalier Universitaire Dijon" with 3 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier William Morey" #1 collaborator was "Amgen" with 2 trials as a collaborator, "Celgene" with 2 trials as a collaborator, "Centre Hospitalier Universitaire Dijon" with 2 trials as a collaborator, "Floralis" with 2 trials as a collaborator and "Intergroupe Francophone du Myelome" with 2 trials as a collaborator. Other collaborators include 44 different institutions and companies that were collaborators in the rest 53 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier William Morey" are "Multiple Myeloma" (8 trials), "Covid19" (2 trials), "Metastatic Breast Cancer" (2 trials), "Myeloma" (2 trials) and "Tomography, Optical Coherence" (2 trials). Many other conditions were trialed in "Centre Hospitalier William Morey" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier William Morey" are "Drug" (33 trials), "Other" (15 trials), "Procedure" (7 trials), "Device" (5 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (3 trials), "Lenalidomide" (3 trials), "Rituximab" (3 trials), "Bleomycin" (2 trials) and "Cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier William Morey" are 56 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Centre Hospitalier William Morey". undefined are not yet recruiting, 14 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in Centre Hospitalier William Morey, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier William Morey, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 10 trials that are defined as “Not Applicable".

Centre Hospitalier William Morey has several departments that took part in Clinical trials: "CH William Morey; Nephrologie" - 2 trials